生物标誌物市场：按产品类型、应用、适应症（癌症、心血管疾病、神经系统疾病、传染病等）、最终用户、地区 - 规模、份额、前景、机会分析，2022~2030 年

生物标誌物是指示生物状态或状况的定量标誌物。 血液、尿液和软组织通常用于测试和研究生物标誌物，以研究典型的生物过程、致病过程或对治疗干预的药理学反应。 生物标誌物用于许多科学领域。 生物标誌物有两种类型：生物标誌物检测试剂盒和生物标誌物分析仪。 按临床用途组织的一套相对较新的临床工具包括医疗行业中使用的生物标誌物。

市场动态

预计市场参与者推出更多产品将推动预测期内的市场增长。 例如，2021 年 4 月 19 日，利用科学和创新将新颖概念和医学发现转化为治疗危及生命疾病患者的治疗方法的全球生物技术公司安进公司宣布推出转移性生物标誌物援助计划，旨在为急性（IV 期）非小细胞肺癌 (NSCLC) 患者提供生物标誌物检测。 确定患者适当治疗的一个重要初始步骤是诊断时的生物标誌物测试。 Biomarker Assist 允许符合条件的患者获得生物标记测试的折扣。

此外，2022 年 2 月 28 日，美国国立卫生研究院 (FNIH) 生物标誌物联盟将宣布最有效的血液测试，以评估对早期发现罕见神经退行性疾□□病很重要的蛋白质。启动一项旨在寻找测试的倡议计划。 神经丝作为家族性额叶变性 (FTD) 中神经变性的流体生物标誌物 这项名为“神经丝作为家族性额叶变性 (FTD) 中神经变性的流体生物标誌物”的研究发现，对这种称为神经丝的蛋白质进行的一项或多项血液测试可以用于识别额叶退化的遗传和家族联繫。我们计划证明我们可以识别有风险的个体 (FTD)。 这是朝着开发一种可靠、廉价、无创的方法以更准确地预测额叶变性 (FTD) 迈出的重要的第一步。 此外，那些感到受到威胁的人可以参与新规格的临床研究，最终将导致治疗的发展。

这项研究的主要特点

• 本报告对全球生物标誌物市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模（十亿美元）和復合年增长率 (CAGR%)。它提供。
• 它还阐明了不同细分市场的潜在创收机会，并描述了该市场具有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数介绍全球生物标誌物市场主要参与者的概况。
• 本研究涵盖的主要公司包括 Agilent Technologies, Inc.、F. Hoffmann-La Roche Ltd.、Acobiom、Apis Assay Technologies Ltd.、Eagle Biosciences, Inc.、Beckman Coulter, Inc.、PerkinElmer Inc.、Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc. ., Abnova Corporation 和 Abbexa
• 这份报告中的见解应该能让企业营销人员和管理人员就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。看来。
• 《全球生物标誌物市场报告》面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球生物标誌物市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第2章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 按产品类型划分的市场概况
  • 市场概况：按应用分类
  • 市场概况：按疾病适应症分类
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 商机
• 影响分析
• 主要发展状况
• 行业趋势
• 监管场景
• 最近的产品批准/发布
• 害虫分析
• 搬运工分析

第 4 章全球生物标誌物市场 - 冠状病毒 (COVID-19) 大流行的影响

• 对需求的影响
• 对医疗保健的影响
• 流行病学

第 5 章全球生物标誌物市场：按类型，2017-2030

• 生物标誌物测试
• 生物标誌物分析仪

第 6 章全球生物标誌物市场：按应用分类，2017-2030

• 诊断生物标誌物
• 用于监测的生物标誌物
• 药物发现和药物开发
• 预测性生物标誌物
• 预后生物标誌物

第 7 章全球生物标誌物市场：按疾病适应症分类，2017-2030

• 癌症
• 心血管疾病
• 神经系统疾病
• 感染
• 其他（免疫性疾病、自身免疫性疾病等）

第 8 章全球生物标誌物市场：最终用户，2017-2030

• 2022 年和 2030 年各地区的市场份额分析 (%)
• 2017-2030 年按地区划分的同比增长分析
• 各地区的趋势
• 医院
  • 2017-2030 年市场规模、预测、同比增长率
• 研究所
  • 2017-2030 年市场规模和预测，同比增长率
• 诊断实验室
  • 2017-2030 年市场规模和预测，同比增长率
• 研究和学术机构
  • 2017-2030 年市场规模、预测、同比增长率

第 9 章全球生物标誌物市场：按地区划分，2017-2030

• 北美
• 美国（美国）
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 德国
• 英国
• 法国
• 意大利
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳大利亚
• 韩国
• 东盟
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 南非
• 中非
• 北非

第10章竞争格局

• 热图分析
• 市场份额分析
  • Agilent Technologies, Inc.
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co., Ltd
  • LifeSpan BioSciences, Inc.
  • Wako USA
  • BioLegend, Inc.
  • Abnova Corporation
  • Abbexa

第 11 章章节

• 调查方法介绍
• 关于出版商

A biomarker is a quantifiable sign of a biological condition or state. In order to investigate typical biological processes, pathogenic processes, or pharmacologic reactions to a therapeutic intervention, biomarkers are frequently examined and studied utilizing blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical toolsets organized by clinical applications includes biomarkers utilized in the medical industry.

Market Dynamics

Increasing product launch by market players is expected to drive the market growth over the forecast period. For instance, on April 19, 2021, Amgen Inc., a global biotechnology company that uses science and innovation to translate novel concepts and medical discoveries into treatments for patients with life-threatening illnesses, announced the launch of the Biomarker Assist program, which aims to provide access to biomarker testing for patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker Assist.

Furthermore, on February 28, 2022, an initiative program was launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium aims to find the most effective blood tests for assessing a protein that is crucial for the early detection of rare neurodegenerative illnesses. The "Neurofilament as a Fluid Biomarker of Neuro degeneration in Familial Front temporal Degeneration (FTD)" study will demonstrate that one or more blood tests for this protein, known as neurofilament, can be used to determine individuals at risk of Front temporal Degeneration (FTD) due to genetic and familial ties. This is a crucial first step in developing a trustworthy, affordable, and non-invasive method to more accurately predict Front temporal Degeneration (FTD). Also, those who are at threat can take part in clinical studies of novel specifics, eventually leading to the development of treatments.

Key features of the study:

• This report provides an in-depth analysis of the global biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
• Key companies covered as a part of this study include Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Acobiom, Apis Assay Technologies Ltd., Eagle Biosciences, Inc., Beckman Coulter, Inc., PerkinElmer Inc., Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc., Abnova Corporation, and Abbexa
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global biomarkers market

Detailed Segmentation:

• Global Biomarkers Market, By Product Type:
  • Biomarker Test Kits
  • Biomarker Analyzer
• Global Biomarkers Market, By Application:
  • Diagnostic Biomarkers
  • Monitoring Biomarkers
  • Drug Discovery And Development
  • Predictive Biomarkers
  • Prognostic Biomarkers
• Global Biomarkers Market, By Disease Indication
  • Cancer
  • Cardiovascular Disease
  • Neurological Disorder
  • Infectious disease
  • Others (Immunological Disorder, and Autoimmune Disorders among others )
• Global Biomarkers Market, By End User:
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Research and Academic Institute
• Global Biomarkers market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Agilent Technologies, Inc. *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co. Ltd
  • LifeSpan BioSciences Inc
  • Wako USA,
  • BioLegend, Inc
  • Abnova Corporation
  • Abbexa

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Key Developments
• Industry Trends
• Regulatory Scenario
• Recent Product Approval/Launches
• PEST Analysis
• Porter's Analysis

4. Global Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

• Impact on Demand
• Impact on Healthcare
• Epidemiology

5. Global Biomarkers Market, By Type, 2017 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biomarker Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Biomarker Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

6. Global Biomarkers Market, By Application, 2017 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Diagnostic Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Monitoring Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Drug discovery and development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Predictive Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Prognostic Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

7. Global Biomarkers Market, By Disease Indication, 2017 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Cardiovascular Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Neurological Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Infectious disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Others (Immunological Disorder, and Autoimmune Disorders among others )
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

8. Global Biomarkers Market, End User, 2017 - 2030 (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030(%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017- 2030, (US$ Bn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017- 2030, (US$ Bn)
• Research and Academic Institute
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

9. Global Biomarker Market, By Region, 2017 - 2030 (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030(%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• North America
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• U.S.
• Canada
• Latin America
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• South Africa
• Central Africa
• North Africa

10. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co., Ltd
  • LifeSpan BioSciences, Inc.
  • Wako USA
  • BioLegend, Inc.
  • Abnova Corporation
  • Abbexa
• Analyst Views

11. Section

• Research Methodology
• About Us